CRISPR Therapeutics AG (CRSP)
38.31
-0.80 (-2.05%)
At close: Apr 25, 2025, 3:59 PM
38.38
0.18%
After-hours: Apr 25, 2025, 05:54 PM EDT
CRISPR Therapeutics Analyst Ratings
Total Analysts
19
Consensus Rating
Buy
Price Target
82
Upside
114.04
Ratings History
| Analyst | Firm | Rating | Action | Price Target | Upside | Date |
| Needham | Buy | Reiterates | 84 84 | 119.26% | Apr 9, 2025 | |
| Cantor Fitzgerald | Hold | Reiterates | n/a | n/a | Feb 19, 2025 | |
| Citigroup | Buy | Maintains | 89 82 | 114.04% | Feb 18, 2025 |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.